Mednet Logo
HomeGynecologic OncologyQuestion

How do you integrate ophthalmic exam and surveillance into routine visits for cervical cancer patients receiving tisotumab vedotin?

1
2 Answers
Mednet Member
Mednet Member
Gynecologic Oncology · Virginia Commonwealth University

The key is to identify and intervene early; in my practice, I personally see patients each cycle (q3 weeks) and do office ophthalmic exams. Look for eye redness, irritation, corneal lesions. Key to avoiding tox is prevention with the vasoconstrictor, steroid, and lubricating drops as well as cool pa...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Gynecologic Oncology · Presbyterian Cancer Care

I would also recommend developing a relationship with a local eye professional. One of the Tivdak reps in our region has reached out to local eye professionals to educate them on these adverse effects. Now that they are familiar with the drug, they are willing to expedite visits for patients that ex...

Register or Sign In to see full answer